Abstract
A series of xanomeline analogs were synthesized and evaluated for binding at the M1 muscarinic acetylcholine receptor (M1 receptor). Specifically, compounds that substitute the O-hexyl chain of xanomeline with polar, ionizable, or conformationally restricted moieties were assessed for their ability to bind to the M1 receptor in a wash-resistant manner (persistent binding). From our screen, several novel ligands that persistently bind to the M1 receptor with greater affinity than xanomeline were discovered. Results indicate that persistent binding may arise not only from hydrophobic interactions but also from ionic interactions with a secondary M1 receptor binding site. Herein, a qualitative model that accounts for both binding scenarios is proposed and applied to understand the structural basis to wash-resistant binding and long-acting effects of xanomeline-based compounds.
Original language | English (US) |
---|---|
Pages (from-to) | 1376-1392 |
Number of pages | 17 |
Journal | Bioorganic and Medicinal Chemistry |
Volume | 16 |
Issue number | 3 |
DOIs | |
State | Published - Feb 1 2008 |
Bibliographical note
Funding Information:This work was supported by NIH Grant NS25743.
Keywords
- Alzheimer's disease
- Drug design
- Long-acting
- M receptor
- Muscarinic
- Plasmalemma diffusion microkinetic model
- Wash-resistant binding
- Xanomeline